Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/1998
06/09/1998US5763218 Nucleic acid encoding novel human G-protein coupled receptor
06/09/1998US5763217 Method of using, process of preparing and composition comprising recombinant herpesvirus vectors
06/09/1998US5763214 Fibroblast growth factor 11
06/09/1998US5763213 Sensory and motor neuron derived factor (SMDF)
06/09/1998US5763212 Binding low molecular mass cell penetrating ligand to protein
06/09/1998US5763211 Polynucleotide which encodes receptor polypeptide
06/09/1998US5763210 Recombinant production of interferon-gamma binding proteins
06/09/1998US5763209 Methods and materials relating to the functional domains of DNA binding proteins
06/09/1998US5763195 Method and compositions for making ACSF and ACSF antagonists
06/09/1998US5763192 Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
06/09/1998US5763188 Probe for diagnosing Escherichia coli, Klebsiella pneumonieae or Enterobacter cloacae
06/09/1998US5763187 Bacterial donor cell useful in conjugation
06/09/1998US5763186 Use of antisense oligomers in a process for controlling contamination in nucleic acid amplification reactions
06/09/1998US5763185 Method for reducing inhibitors of nucleic acid hybridization
06/09/1998US5763184 Nucleotide sequence variation in the ABO glycosyltransferase gene
06/09/1998US5763180 In vitro assay for carcinogens using phenotypic transformation of human cells
06/09/1998US5763178 Oscillating signal amplifier for nucleic acid detection
06/09/1998US5763177 Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
06/09/1998US5763173 Nucleic acid ligand inhibitors to DNA polymerases
06/09/1998US5763171 Nucleic acid structures with catalytic and autocatalytic replicating features and methods of use
06/09/1998US5763169 Nucleic acid probes for the detection and identification of fungi
06/09/1998US5763168 Analysing the dna sequence of the angiotensinogen gene
06/09/1998US5763167 Applications of fluorescent N-nucleosides and fluorescent structural analogs of N-nucleosides
06/09/1998US5763166 Gene associated with X linked Kallmann syndrome and diagnostic applications therefrom
06/09/1998US5763164 Immunogenic cancer proteins and peptides and methods of use
06/09/1998US5763159 Hepatitis-C virus testing
06/09/1998US5762939 Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
06/09/1998US5762938 Modified recombinant vaccinia virus and expression vectors thereof
06/09/1998US5762934 Clostridium difficile toxin disease therapy
06/09/1998US5762924 Wherein heterologous dna is located in the genome at the site of spindle protin gene; pesticides, insecticides
06/09/1998US5762921 Composition and methods for the treatment of tumors
06/09/1998US5762905 Human neutralizing monoclonal antibodies to respiratory syncytial virus
06/09/1998CA2218200A1 Gpi-ceruloplasmin, analogs thereof, and methods of use
06/09/1998CA2192407A1 Ceruloplasmin analogs and methods of use
06/09/1998CA1339901C Pollen-mediated plant transformation
06/04/1998WO1998023964A1 METHOD TO DETECT IgE
06/04/1998WO1998023781A1 Ligand detection system and methods of use thereof
06/04/1998WO1998023780A1 Methods for diagnosing and treating diabetes
06/04/1998WO1998023777A2 Assay for detecting apoptotic cells
06/04/1998WO1998023775A2 Dna for evaluating the progression potential of cervical lesions
06/04/1998WO1998023774A1 Fen-1 endonucleases, mixtures and cleavage methods
06/04/1998WO1998023771A1 A new eia test using non-dentured hiv antigen for early detection of hiv infection
06/04/1998WO1998023765A1 Transfecting composition usable in gene therapy combining a recombinant virus incorporating an exogenous nucleic acid, a non-viral and non-plasmid transfecting agent
06/04/1998WO1998023764A1 Truncated cbh i promoter from trichoderma reesei and use thereof
06/04/1998WO1998023763A1 Heterologous antigens in live cell v. cholerae strains
06/04/1998WO1998023762A2 Methods of producing a recombinant protein
06/04/1998WO1998023761A1 HUMANIZED ANTI-CD11a ANTIBODIES
06/04/1998WO1998023760A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit
06/04/1998WO1998023759A2 Identification of inhibitors that prevent access of telomerase to chromosomal terminus
06/04/1998WO1998023758A1 Human glutathione s-transferase
06/04/1998WO1998023757A1 Transgenic plants having increased starch content
06/04/1998WO1998023755A1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
06/04/1998WO1998023754A1 Process for the expression of genes of the dengue viruses
06/04/1998WO1998023753A1 Systems for determining substances active against hpv-associated diseases
06/04/1998WO1998023752A2 Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses
06/04/1998WO1998023751A1 Processed polypeptides with il-16 activity, processes for their production and their use
06/04/1998WO1998023750A2 Mammalian chemokines
06/04/1998WO1998023749A1 Fibroblast growth factor-13
06/04/1998WO1998023748A1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3)
06/04/1998WO1998023747A2 Isolated mammalian dendritic cell genes; related reagents
06/04/1998WO1998023746A1 Antibody mutants
06/04/1998WO1998023745A1 Human sqm1 protein homolog comprising a cell adhesion protein
06/04/1998WO1998023744A1 Novel human rna-binding protein
06/04/1998WO1998023743A1 Murine guanine nucleotide exchange factor - (mngef) and human homologues thereof
06/04/1998WO1998023742A1 A NOVEL CLONED GABA-RECEPTOR SUBUNIT cDNA SEQUENCE AND STABLY CO-TRANSFECTED CELL LINES
06/04/1998WO1998023741A1 Mutants of the lag-3 proteins, products for the expression of these mutants and use
06/04/1998WO1998023740A1 Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis
06/04/1998WO1998023739A1 Novel gene encoding male-transplantation antigen
06/04/1998WO1998023738A2 Novel prokaryotic polynucleotides, polypeptides and their uses
06/04/1998WO1998023736A1 A method for isolating phenotype related gene and their switch region as well as their switch molecular
06/04/1998WO1998023735A1 Immune responses using compositions containing stress proteins
06/04/1998WO1998023731A2 Chimeric target molecules having a regulatable activity
06/04/1998WO1998023642A1 Genes encoding transcriptional regulatory proteins from trichoderma reesei and uses thereof
06/04/1998WO1998023641A1 Dna encoding lepidopteran-active delta-endotoxins and its use
06/04/1998WO1998023638A2 Complement inhibitor
06/04/1998WO1998023633A1 Identifying mammalian genes
06/04/1998WO1998023632A1 An optimal procedure for isolation of mutant mitochondrial alleles
06/04/1998WO1998023631A1 Novel bacterial polypeptides and polynucleotides
06/04/1998WO1998023379A1 Method and device for separating particles or molecules by migration through a ferrofluid
06/04/1998WO1998023294A1 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
06/04/1998WO1998023282A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
06/04/1998WO1998023155A1 Arthropodicidal and fungicidal cyclic amides
06/04/1998WO1998013493A3 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
06/04/1998WO1998011238A3 Protease m, a novel serine protease
06/04/1998WO1998011235A3 Transgenic plants expressing cellulolytic enzymes
06/04/1998WO1997049813A3 Glucuronide repressors and uses thereof
06/04/1998DE19649233A1 Nucleic acid encoding interleukin-16 polypeptide
06/04/1998CA2274313A1 Mammalian chemokines
06/04/1998CA2274143A1 Murine guanine nucleotide exchange factor - (mngef) and human homologues thereof
06/04/1998CA2272989A1 Identification of inhibitors that prevent access of telomerase to chromosomal terminus
06/04/1998CA2272988A1 Methods of producing a recombinant protein
06/04/1998CA2272987A1 Novel gene encoding male-transplantation antigen
06/04/1998CA2272900A1 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
06/04/1998CA2272847A1 Dna encoding lepidopteran-active delta-endotoxins and its use
06/04/1998CA2272846A1 Processed polypeptides with il-16 activity, processes for their production and their use
06/04/1998CA2272637A1 Transfecting composition usable in gene therapy combining a recombinant virus incorporating an exogenous nucleic acid, a non-viral and non-plasmid transfecting agent
06/04/1998CA2272536A1 Immune responses using compositions containing stress proteins
06/04/1998CA2272345A1 Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis
06/04/1998CA2272243A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
06/04/1998CA2272239A1 Fibroblast growth factor-13